Clear evidence of the carcinogenic potential of anthracene: A 2‐year feeding study in rats and mice
Authors:
- 7 December 2022
- journal article
- research article
- Published by Wiley in Environmental Toxicology
- Vol. 38 (4) , 709-726
Abstract
Anthracene is an environmental pollutant and its adverse effects on human health have long been a concern due to its persistence and bioaccumulation properties. However, there is insufficient evidence for its chronic toxicity, especially carcinogenicity, in either humans or experimental animals. In this study, its carcinogenicity and chronic toxicity were investigated in compliance with the OECD test guideline 451 (OECD TG 451) and Good Laboratory Practice Standards. Fifty male and 50 female F344 rats and 50 female BDF1 mice were administrated 0, 8000, 20000, or 50000 ppm anthracene in the diet for 104 weeks, and 50 male BDF1 mice were fed diets containing anthracene at 0, 3200, 8000, or 20000 ppm. Anthracene treatment had no adverse effect on either the survival rate or general condition of the rats or mice during the study period. Body weights were lower or tended to be lower in the anthracene‐treated groups than in the control groups. Increased incidence of hepatocellular carcinoma and hepatocellular adenoma was observed in male rats and female mice. Renal cell carcinoma and renal cell adenoma, fibroadenoma in the mammary gland, and uterine endometrial stromal sarcoma were increased in female rats. Transitional cell carcinoma and transitional cell papilloma in the urinary bladder were also increased in male and female rats. In addition, several different pre‐neoplastic lesions were increased in the anthracene‐treated male and female rats and female mice. These results provide clear evidence that oral administration of anthracene for 104 weeks has a carcinogenic effect in male and female rats and female mice.Keywords
This publication has 15 references indexed in Scilit:
- Occurrence of polycyclic aromatic hydrocarbons in human diet - exposure and risk assessment to consumer healthRoczniki Panstwowego Zakladu Higieny, 2021
- Emerging organic contaminants in shallow groundwater underlying two contrasting peri-urban areas in UgandaEnvironmental Monitoring and Assessment, 2021
- Safety of natural anthraquinone emodin: an assessment in miceBMC Pharmacology and Toxicology, 2021
- Heavy Metals and PAHs in Meat, Milk, and Seafood From Augusta Area (Southern Italy): Contamination Levels, Dietary Intake, and Human Exposure AssessmentFrontiers in Public Health, 2020
- Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung CancerToxicological Sciences, 2015
- Sensitive and robust UPLC–MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronideJournal of Pharmaceutical and Biomedical Analysis, 2011
- Polycyclic Aromatic Hydrocarbons (PAHs) in Soil and Sediment from Industrial, Residential, and Agricultural Areas in Central South Africa: An Initial AssessmentSoil and Sediment Contamination: An International Journal, 2011
- Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97Mutation Research/Genetic Toxicology, 1985
- Gas chromatography/mass spectrometric and nuclear magnetic resonance spectrometric studies of carcinogenic polynuclear aromatic hydrocarbons in tobacco and marijuana smoke condensatesAnalytical Chemistry, 1976
- Metabolism of polycyclic compounds. 25. The metabolism of anthracene and some related compounds in ratsBiochemical Journal, 1964